Health & Environmental Research Online (HERO)


Print Feedback Export to File
3009236 
Journal Article 
In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites 
Zhang, J; Kamstra, JH; Ghorbanzadeh, M; Weiss, JM; Hamers, T; Andersson, PL 
2015 
Yes 
Environmental Science and Technology
ISSN: 0013-936X
EISSN: 1520-5851 
49 
16 
10099-10107 
English 
Thyroid hormone disrupting chemicals (THDCs) interfere with the thyroid hormone system and may induce multiple severe physiological disorders. Indoor dust ingestion is a major route of THDCs exposure in humans, and one of the molecular targets of these chemicals is the hormone transporter transthyretin (TTR). To virtually screen indoor dust contaminants and their metabolites for THDCs targeting TTR, we developed a quantitative structure-activity relationship (QSAR) classification model. The QSAR model was applied to an in-house database including 485 organic dust contaminants reported from literature data and their 433 in silico derived metabolites. The model predicted 37 (7.6%) dust contaminants and 230 (53.1%) metabolites as potential TTR binders. Four new THDCs were identified after testing 23 selected parent dust contaminants in a radio-ligand TTR binding assay; 2,2',4,4'-tetrahydroxybenzophenone, perfluoroheptanesulfonic acid, 3,5,6-trichloro-2-pyridinol, and 2,4,5-trichlorophenoxyacetic acid. These chemicals competitively bind to TTR with 50% inhibition (IC50) values at or below 10 μM. Molecular docking studies suggested that these THDCs interacted similarly with TTR via the residue Ser117A, but their binding poses were dissimilar to the endogenous ligand T4. This study identified new THDCs using an in silico approach in combination with bioassay testing and highlighted the importance of metabolic activation for TTR binding. 
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFHpS (375-92-8)
          Literature Search
               Pubmed
               WOS
• PFHpS
     Literature Search
          Pubmed
          WOS
     Screening Results
          In vitro/ex vivo/in silico
               Receptor activation